GABRG2 rs2653349: Understanding Genetic Associations and Epilepsy
The rs2653349 variant is a genetic change located within the GABRG2 gene, which provides instructions for making a subunit of the GABAA receptor. Research has investigated this variant for potential associations with epilepsy susceptibility and variations in how individuals respond to certain anticonvulsant medications.
What each genotype means
Common genetic variant profile
This genotype represents the most frequently observed sequence at this position in the GABRG2 gene. Research into GABRG2 variants primarily focuses on rare, pathogenic mutations associated with epilepsy syndromes rather than this common variant. Please consult with your healthcare provider if you have specific concerns regarding neurological health or medication response.
This is the most common genotype found across global populations.
Common genetic variant profile
This genotype indicates you carry one copy of the common allele and one copy of the alternative allele at this position. Current scientific literature does not identify this specific common variant as a primary driver of epilepsy or altered drug response. Discuss any personal or family health history with a clinician to determine if further genetic evaluation is appropriate.
This genotype is observed at varying frequencies depending on ancestral background, typically appearing in a significant portion of the general population.
Common genetic variant profile
This genotype represents the alternative sequence at this position. While the GABRG2 gene is known to harbor rare mutations linked to epilepsy and anticonvulsant response, this specific common variant is not established as a clinical marker for these conditions. Always consult a pharmacist or physician regarding the management of any prescribed medications.
This genotype is present in the general population, with frequencies varying by ancestral group.
What is the rs2653349 Variant?
The rs2653349 variant is a single-nucleotide polymorphism (SNP) found within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that influences the expression or function of the GABRG2 protein. Because the GABRG2 gene is critical for brain function, researchers often study variants within this gene to understand how subtle changes in DNA might contribute to neurological conditions. It is important to note that the presence of a specific SNP does not automatically mean an individual will develop a health condition; rather, it is one of many factors—including other genetic markers, environmental influences, and lifestyle—that contribute to an individual's overall health profile.
The Role of the GABRG2 Gene
The GABRG2 gene encodes the gamma-2 subunit of the GABAA receptor, which is a primary inhibitory neurotransmitter receptor in the human brain. These receptors act like 'brakes' for the nervous system, helping to regulate electrical activity and prevent over-excitation of neurons. When GABAA receptors function correctly, they maintain a balance of signaling that is essential for normal brain activity. Mutations or variations in GABRG2 can potentially alter the assembly, trafficking, or kinetics of these receptors. Because these receptors are the targets of many anticonvulsant medications, researchers are interested in whether genetic variations in GABRG2 might influence how effectively these drugs work in different people. Understanding this gene is a major focus in neurogenetics, particularly regarding how receptor dysfunction relates to seizure disorders.
Research and Evidence Strength
The evidence linking rs2653349 to specific clinical outcomes is currently considered limited. While some studies have explored associations between GABRG2 variants and epilepsy susceptibility or drug response, results have often been inconsistent across different populations. For instance, some research suggests that certain GABRG2 polymorphisms may correlate with seizure risk, but these findings are not always replicated in larger, more diverse cohorts. Furthermore, the role of GABRG2 in predicting how a patient will respond to specific anticonvulsant medications remains an area of active investigation rather than established clinical practice. Because epilepsy is a complex, polygenic condition, it is difficult to isolate the effect of a single SNP. Consequently, this variant should not be used as a standalone tool for diagnosis or treatment planning.
Population Frequency
The rs2653349 variant is considered a common SNP, meaning it is found at a relatively high frequency across many global populations. Because it is common, it is present in many healthy individuals who do not have epilepsy or other neurological conditions. The specific frequency of the alleles can vary significantly depending on ancestral background, which is a common observation in genetic studies. This widespread distribution reinforces the idea that the variant is likely a normal part of human genetic diversity rather than a rare, highly penetrant mutation that directly causes disease on its own.
What You Can and Cannot Do With This Information
Genetic information regarding rs2653349 is intended for educational purposes and should not be used to make personal health decisions. You cannot use this information to diagnose yourself with epilepsy or to predict how you will respond to a specific medication. If you are currently taking anticonvulsant medication or have concerns about seizure risk, it is essential to discuss these topics with your neurologist or primary care physician. They can provide context based on your full medical history, clinical symptoms, and established diagnostic criteria. Never change your medication dosage or stop taking prescribed treatments based on genetic test results without consulting your healthcare provider. Genetic testing for common variants is a tool for research and understanding, not a substitute for professional medical evaluation.
How common is this variant?
The rs2653349 variant is a common polymorphism found across various global populations, with its specific allele frequencies varying by ancestry.
Frequently asked questions
Does having the rs2653349 variant mean I have epilepsy?
No. This variant is common in the general population, including in people who do not have epilepsy. It is not a diagnostic marker for the condition.
Can I use this SNP to choose the best seizure medication?
No. There is currently no clinical evidence to support using this SNP to guide medication selection. Always follow the treatment plan prescribed by your doctor.
Is this variant considered a 'mutation'?
In genetics, this is typically referred to as a polymorphism or variant because it is common in the population. The term 'mutation' is usually reserved for rare, disease-causing changes.
Where can I find more information about GABRG2?
You can search resources like MedlinePlus Genetics or the NCBI Gene database for comprehensive information on the GABRG2 gene and its biological functions.
Sources & further reading
Educational information only, last refreshed 10/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2653349?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is associated with susceptibility to childhood absence epilepsy and febrile seizures.